在患有癌症和心力衰竭的患者中 Midodrine 使用的评估
Jorge A Irizarry-Caro1, Juhee Song2, Chase Miller1
1Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
在心力衰竭 (HF) 的癌症患者中,米多林治疗没有增加副作用或死亡风险. 这项研究表明,在这个人群中,中是控制低血压的安全选择.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症患者经常出现低血压,需要治疗.
- 同时心力衰竭 (HF) 复杂化了低血压的管理.
- 米多德林用于治疗低血压,但其在患有高血压的癌症患者中的安全性尚未得到充分证实.
研究的目的:
- 评估 midodrine 的安全性和心血管结果在患有高血压的癌症患者中.
- 为了评估这一患者群体的整体存活率,当治疗中林治疗低血压时.
主要方法:
- 对接受中林治疗的HF成人癌症患者的回顾性分析.
- 收集关于人口统计,临床参数和结果的数据.
- 随访时间中位数为38个月.
主要成果:
- 包括85名患者;31%的HFpEF,42%的HFmrEF,27%的HFrEF.
- 最常见的适应症是静止性低血压 (49%).
- 上高血压发生在6%的患者中;心脏标志物或住院病例没有显著变化.
- 持续服用米多德林和用于静止性低血压的使用与死亡率的增加无关.
结论:
- 在患有HF的癌症患者中使用米多德林似乎是安全的.
- 没有观察到任何显著的不良影响,更糟糕的心血管结果或增加的死亡率.
- 建议进行更大规模的前性研究来证实这些发现.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Diuretics
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
